Regeneron says COVID antibody treatment may be less effective against Omicron
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for COVID-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
Nov 30, 2021
0
4